In conclusion, we used the state-of-the-art mass spectrometry platforms to characterize the cell surface N-glycome, proteome, and glycan distribution maps of a cohort of Filipino lung cancer samples (n = 5), who were previously characterized clinically for ALK and EGFR mutations. The gene discussed is EGFR; the disease is lung cancer.